These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34532923)

  • 1. Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Allosio P; Amendola MF; Aricò S; Baselice A; Balbinot P; Campanile V; Fanucchi T; Macciò L; Meneguzzi C; Mioni D; Parisi M; Renzetti D; Rossin R; Gandin C; Bottaro LC; Caio G; Lungaro L; Zoli G; Scafato E; Caputo F
    Addict Biol; 2022 Jan; 27(1):e13090. PubMed ID: 34532923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Allosio P; Amendola MF; Aricò S; Baselice A; Balbinot P; Campanile V; Fanucchi T; Greco G; Macciò L; Meneguzzi C; Mioni D; Palmieri VO; Parisi M; Renzetti D; Rossin R; Gandin C; Bottaro LC; Bernardi M; Addolorato G; Lungaro L; Zoli G; Scafato E; Caputo F
    Dig Dis Sci; 2022 Jun; 67(6):1975-1986. PubMed ID: 34142284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Da BL; Im GY; Schiano TD
    Hepatology; 2020 Sep; 72(3):1102-1108. PubMed ID: 32369624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Scafato E; Caputo F;
    Dig Liver Dis; 2020 Jan; 52(1):21-32. PubMed ID: 31757596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 and alcohol associated liver disease.
    Deutsch-Link S; Curtis B; Singal AK
    Dig Liver Dis; 2022 Nov; 54(11):1459-1468. PubMed ID: 35933291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Recent SARS-CoV-2 Infection With New-Onset Alcohol Use Disorder, January 2020 Through January 2022.
    Olaker VR; Kendall EK; Wang CX; Parran TV; Terebuh P; Kaelber DC; Xu R; Davis PB
    JAMA Netw Open; 2023 Feb; 6(2):e2255496. PubMed ID: 36757694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic.
    Busch AB; Mehrotra A; Greenfield SF; Uscher-Pines L; Rose S; Huskamp HA
    J Subst Abuse Treat; 2023 Jan; 144():108920. PubMed ID: 36334384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation.
    Arab JP; Izzy M; Leggio L; Bataller R; Shah VH
    Nat Rev Gastroenterol Hepatol; 2022 Jan; 19(1):45-59. PubMed ID: 34725498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of COVID-19 on trends in alcohol use disorder treatment in Veterans Health Administration.
    Perumalswami PV; Kilpatrick S; Frost MC; Adams MA; Kim HM; Zhang L; Lin L
    Addiction; 2023 Jun; 118(6):1062-1071. PubMed ID: 36738085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality.
    Bailey KL; Sayles H; Campbell J; Khalid N; Anglim M; Ponce J; Wyatt TA; McClay JC; Burnham EL; Anzalone A; Hanson C
    Alcohol Clin Exp Res; 2022 Jun; 46(6):1023-1035. PubMed ID: 35429004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge.
    Klain M; Nappi C; Maurea S; De Risi M; Volpe F; Caiazzo E; Piscopo L; Manganelli M; Schlumberger M; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):831-836. PubMed ID: 32965559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol sales during COVID-19 social restrictions: Initial evidence from Alcoholic Beverage Control states.
    Morton CM
    Subst Abus; 2021; 42(2):158-160. PubMed ID: 33709878
    [No Abstract]   [Full Text] [Related]  

  • 14. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study.
    Guarino M; Cossiga V; Fiorentino A; Pontillo G; Morisco F
    J Med Internet Res; 2020 Sep; 22(9):e20874. PubMed ID: 32896833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Ophthalmology: Telemedicine in a COVID-19 Era.
    Saleem SM; Pasquale LR; Sidoti PA; Tsai JC
    Am J Ophthalmol; 2020 Aug; 216():237-242. PubMed ID: 32360862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis.
    Alexandre W; Muhammad H; Agbalajobi O; Zhang G; Gmelin T; Adejumo A; Noll A; Jonassaint NL; DiMartini A; Bataller R; Rogal SS
    BMC Gastroenterol; 2023 Feb; 23(1):29. PubMed ID: 36732709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.
    Aghemo A; Masarone M; Montagnese S; Petta S; Ponziani FR; Russo FP;
    Dig Liver Dis; 2020 Sep; 52(9):937-941. PubMed ID: 32703730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplant immunosuppression during the covid-19 pandemic.
    Forns X; Navasa M
    Gastroenterol Hepatol; 2020 Oct; 43(8):457-463. PubMed ID: 32646657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.